Literature DB >> 9480398

[Diagnosis and therapy of hepatocellular carcinoma].

H Reinwald1.   

Abstract

During the past decade, the diagnostic technologies concerning the hepatocellular carcinoma have been enriched by the vascular doppler ultrasound, the ultrasound echo-enhancing agents and the magnetic resonance tomography. The therapeutic possibilities have been augmented by the percutaneous ethanol instillation therapy, the combination of local therapies with transcatheter arterial embolisation and the more effective after-treatment after transplantation and segment resection. The use of the respective treatment modalities depends on the tumor constellation, the functional liver reserve, the patients general condition and the risk/benefit ratio of the treatment. The quality of life should be optimized because of the poor tumor prognosis. As there have been no real advances in the treatment of hepatocellular carcinoma to date, the prevention and early diagnosis of the tumor in high risk populations is of utmost importance.

Entities:  

Mesh:

Year:  1997        PMID: 9480398     DOI: 10.1007/bf03044823

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  37 in total

1.  Percutaneous ethanol injection for the treatment of hepatic tumors: indications, mechanism of action, technique, and efficacy.

Authors:  M J Lee; P R Mueller; S L Dawson; S G Gazelle; P F Hahn; M A Goldberg; G W Boland
Journal:  AJR Am J Roentgenol       Date:  1995-01       Impact factor: 3.959

2.  Combination therapy with transcatheter arterial embolization and percutaneous ethanol injection for advanced hepatocellular carcinoma.

Authors:  M Koda; K Okamoto; Y Miyoshi; S Kato; Y Murawaki; Y Horie; T Suou; H Kawasaki
Journal:  Hepatogastroenterology       Date:  1994-02

3.  Efficacy of combination treatment--(TAE with adriamycin and ethanol)--for hepatocellular carcinoma.

Authors:  Y Hasuike; J Okamura; J Furukawa; M Naoi; N Takata; H Maruyama; M Kinuta; E Yayoi; H Oi; S Okamoto
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Contrast-enhanced MR imaging of hepatic lesions treated with percutaneous ethanol ablation therapy.

Authors:  H S Nagel; M E Bernardino
Journal:  Radiology       Date:  1993-10       Impact factor: 11.105

5.  Hepatocellular carcinoma: use of color Doppler US to evaluate response to treatment with percutaneous ethanol injection.

Authors:  R Lencioni; D Caramella; C Bartolozzi
Journal:  Radiology       Date:  1995-01       Impact factor: 11.105

6.  [Analysis of blood flow in hepatic tumors by color Doppler ultrasonography].

Authors:  M Oguma; M Kawano; T Monma
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  1994-03

Review 7.  Management options for primary hepatocellular carcinoma. An overview.

Authors:  J A Paraskevopoulos
Journal:  Acta Oncol       Date:  1994       Impact factor: 4.089

8.  Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients.

Authors:  T Livraghi; L Bolondi; S Lazzaroni; G Marin; A Morabito; G L Rapaccini; A Salmi; G Torzilli
Journal:  Cancer       Date:  1992-02-15       Impact factor: 6.860

9.  Intra-arterial alcoholization of advanced hepatocellular carcinoma.

Authors:  K Ito; H Kusunoki; E Okamoto; M Ozawa; A Ishikawa; M Matsuura; N Nakajima
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

10.  [Color-coded Doppler sonography of primary and secondary liver tumors].

Authors:  N Börner; T Clement; P Herzog; K F Kreitner; H Miltenberger; H Schild; J Meyer
Journal:  Ultraschall Med       Date:  1990-12       Impact factor: 6.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.